What is an affordable TB testing kit business in India?

It is a business that manufactures or sources low-cost TB diagnostic kits (using tongue or nasal swabs) and sells them to government health clinics, NGOs, and rural centres. The kits must be ICMR-approved and cost ₹40-80 each. India has 3,00,000 TB deaths yearly, with most happening in rural areas due to delayed diagnosis — this business closes that gap.

How much does it cost to start a TB testing kit business in India?

₹15-25 lakh initial investment. Breakdown: ₹8-10 lakh for 10,000-15,000 units of kits at ₹30-40 per unit wholesale cost, ₹3-5 lakh for ICMR/NABL certification and regulatory approvals, ₹2-3 lakh for packaging and branding in local languages, ₹2-3 lakh working capital. You can start without manufacturing — by sourcing certified kits and rebranding them.

Is a TB testing kit business profitable in India?

Yes. Profit margin is 30-50% per kit. If you buy kits at ₹40 and sell to government clinics at ₹60-80 or to private practitioners at ₹100-150, margin is strong. Selling 50,000 kits annually at ₹20 profit = ₹10 lakh gross profit. Scale to 2-3 lakh kits = ₹40-60 lakh annual profit. Government TB programmes and rural health missions are mandated to use approved kits — demand is guaranteed.

What regulations apply to a TB testing kit business in India?

TB diagnostic kits are regulated by ICMR (Indian Council of Medical Research) and NABL (National Accreditation Board for Testing and Calibration Laboratories). You need ICMR approval or NABL certification before selling. GST is 5% on diagnostic kits. The Revised National TB Control Programme (RNTCP) guidelines mandate use of WHO-approved or ICMR-approved tests. The TB Control Act, 1993, governs TB diagnostics in India. Import duty is zero if kits are sourced domestically.

TB Testing Kits India 2026 — Rural Diagnostics Business

AI SummaryIndia's TB crisis presents a ₹500-800 crore annual opportunity in affordable diagnostic kits. With 3,00,000 TB deaths yearly — nearly half within 2 weeks of diagnosis — rural and tribal communities lack access to quick, low-cost testing. Non-invasive tongue and nasal swab-based kits can be manufactured or sourced at ₹30-40 per unit and sold at ₹60-150 to government clinics, NGOs, and private practitioners, creating 30-50% margins. Entrepreneurs with ₹15-25 lakh capital and ICMR certification knowledge can start immediately; government TB programmes and health missions are mandated buyers. States like Jharkhand, Chhattisgarh, and Odisha (high TB burden) are priority markets.